tirzepatide opinie review article for diabetes: on track to SURPASS current therapy Tirzepatide as Compared with Semaglutide – Eden Tirzepatide Program Explained |

Patients provide detailed medical history, including previous GLP-1 use, current medications, weight loss history, and specific goals

doi: 10.1038/s41598-018-25397-6 127 LatorreJOrtegaFJLiares-PoseLMoreno-NavarreteJMLluchAComasFet al

Clinical Trial Findings on Inflammatory Markers The SURPASS clinical trial program, which included more than 10,000 people in various studies, found that patients who were given tirzepatide had significantly lower amounts of high-sensitivity C-reactive protein (hs-CRP)

Skin Type: Suitable for all-over use, including sensitive areas

But that changed with the approval and launch of the Wegovy pill in December 2025 and then again with the launch of Foundayo in April 2026